Literature DB >> 2022643

A coenzyme A-independent transacylase is linked to the formation of platelet-activating factor (PAF) by generating the lyso-PAF intermediate in the remodeling pathway.

Y Uemura1, T C Lee, F Snyder.   

Abstract

The remodeling pathway for the biosynthesis of platelet-activating factor (PAF) consists of the following reaction sequence: alkylacylglycerophosphocholine----lyso-PAF----PAF. Results presented in this article describe a novel transacylase activity that generates the lyso-PAF intermediate, which can then be acetylated to form PAF. Ethanolamine-containing lysoplasmalogens, 1-acyl-2-lyso-sn-glycero-3-phosphoethanolamine, alkyllysophosphoethanolamine, unlabeled lyso-PAF, 1-acyl-2-lyso-GPC, where GPC is sn-glycero-3-phosphocholine, and choline-containing lysoplasmalogens were all able to stimulate the formation of [3H]lyso-PAF from a [3H]alkylacyl-GPC precursor pool associated with HL-60 cell (granulocytic type) membranes. Other glycerolipids containing free hydroxyl groups (3-alkyl-2-lyso-sn-glycero-1-phosphocholine, lysophosphatidylserine, lysophosphatidylinositol, diacylglycerols, alkylglycerols, and monoacylglycerols), cholesterol, phosphatidylcholine, and phosphatidylethanolamine had no stimulatory effect on the release of [3H]lyso-PAF from the prelabeled membranes under identical incubation conditions. The observed transacylase reaction is directly coupled to PAF production, since the addition of a lysoethanolamine plasmalogen preparation to HL-60 membranes in the presence of [14C]acetyl-CoA stimulated PAF formation; under these conditions the lysoethanolamine plasmalogen was acylated. The transacylase responsible for the release of lyso-PAF from the membrane-associated alkylacyl-GPC was not affected by Ca2+, EGTA, or a known phospholipase A2 inhibitor, p-bromophenacyl bromide. The fact that the unnatural analog of lyso-PAF, lysophosphatidylserine, and lysophosphatidylinositol did not influence transacylase activity, whereas detergents such as deoxycholate and Triton X-100 inhibited the activity, demonstrated the observed stimulatory effects of the choline- and ethanolamine-containing lysophospholipids on the formation of [3H]lyso-PAF from [3H]alkylacyl-GPC were not due to any detergent property of these lysophospholipids. Thus, we conclude a CoA-independent transacylase (possessing phospholipase A2/acyltransferase activities) can be responsible for the formation of the lyso-PAF intermediate in the remodeling route of PAF biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022643

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Activities of enzymes involved in the metabolism of platelet-activating factor in neural cell cultures during proliferation and differentiation.

Authors:  E Francescangeli; D Lang; H Dreyfus; A Boila; L Freysz; G Goracci
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

Review 2.  Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases.

Authors:  Yulong Liu; Lisa B E Shields; Zhongwen Gao; Yuanyi Wang; Yi Ping Zhang; Tianci Chu; Qingsan Zhu; Christopher B Shields; Jun Cai
Journal:  Mol Neurobiol       Date:  2016-09-09       Impact factor: 5.590

3.  The regulation of CoA-independent transacylation reactions in neuronal nuclei by lysophospholipid, free fatty acid, and lysophospholipase: the control of nuclear lyso platelet-activating factor metabolism.

Authors:  R R Baker; H Y Chang
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

Review 4.  Metabolic processing of PAF.

Authors:  F Snyder
Journal:  Clin Rev Allergy       Date:  1994

Review 5.  Platelet-activating factor: the biosynthetic and catabolic enzymes.

Authors:  F Snyder
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

6.  Proliferation-dependent changes in release of arachidonic acid from endothelial cells.

Authors:  R E Whatley; K Satoh; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell.

Authors:  M Triggiani; A N Fonteh; F H Chilton
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

8.  Lipid changes in HL-60 cells on differentiation into macrophages by treatment with a phorbol ester.

Authors:  R Manning; A Fallani; S Ruggieri
Journal:  Lipids       Date:  1995-09       Impact factor: 1.880

9.  Influence of arachidonic acid on indices of phospholipase A2 activity in the human neutrophil.

Authors:  J D Winkler; C M Sung; W C Hubbard; F H Chilton
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

10.  Emerging roles of PAR-1 and PAFR in melanoma metastasis.

Authors:  Vladislava O Melnikova; Gabriel J Villares; Menashe Bar-Eli
Journal:  Cancer Microenviron       Date:  2008-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.